Retatrutide is a newly developed therapy that acts as a potent GLP-1 receptor agonist. This breakthrough method holds significant hope for regulating type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide improves insulin secretion and suppresses glucagon release, leading to improved glucose control. Clinical trials have demonstrat